Ad is loading...
SBHIX
Price
$24.16
Change
-$0.59 (-2.38%)
Updated
Nov 15 closing price
THISX
Price
$92.91
Change
-$3.08 (-3.21%)
Updated
Nov 15 closing price
Ad is loading...

SBHIX vs THISX

Header iconSBHIX vs THISX Comparison
Open Charts SBHIX vs THISXBanner chart's image
Saratoga Health & Biotechnology I
Price$24.16
Change-$0.59 (-2.38%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Health Sciences I
Price$92.91
Change-$3.08 (-3.21%)
VolumeN/A
CapitalizationN/A
SBHIX vs THISX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SBHIX vs. THISX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SBHIX is a Sell and THISX is a StrongSell.

FUNDAMENTALS
Fundamentals
THISX has more cash in the bank: 14.1B vs. SBHIX (11.7M). SBHIX (0.00) and THISX (0.00) have matching dividends . SBHIX was incepted earlier than THISX: SBHIX (22 years) vs THISX (9 years). SBHIX is a more actively managed with annual turnover of: 58.00 vs. THISX (48.40). SBHIX has a lower initial minimum investment than THISX: SBHIX (250) vs THISX (500000). THISX annual gain was more profitable for investors over the last year : 9.01 vs. SBHIX (8.15). THISX return over 5 years is better than : 14.97 vs. SBHIX (3.65).
SBHIXTHISXSBHIX / THISX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years9 years-
Gain YTD6.5265.436120%
Front LoadN/AN/A-
Min. Initial Investment2505000000%
Min. Initial Investment IRAN/AN/A-
Net Assets11.7M14.1B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year8.159.0190%
Returns for 3 years-0.94-18.005%
Returns for 5 years3.6514.9724%
Returns for 10 years-28.61N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSFKX20.77-0.05
-0.24%
MFS Total Return R6
NREMX19.55-0.09
-0.46%
Neuberger Berman Emerg Mkts Eq R6
JRSIX12.18-0.14
-1.14%
JH Adaptive Risk Mgd U.S. Eq I
GCGVX20.66-0.26
-1.24%
Goldman Sachs U.S. Equity ESG C
GSMYX25.18-0.48
-1.87%
Goldman Sachs Small/Mid Cap Growth Instl